(ThyBlackMan.com) Michael Giuffrida is a respected and experience surgeon who operates in hospitals across Hartford and Southington in particular. His specializations lie in general surgery and in minimally invasive surgery. For the latter, demand has increased significantly not just in Hartford and Southington, but across the country. This is why Dr. Giuffrida has complete a piece of research into the changing demands for this particular specialization in 2018.
2018 Minimally Invasive Surgery According to Michael Giuffrida
One of the particular demands for this type of surgery is in spine surgery. Specifically, Michael Giuffrida has looked at what classified as minimally invasive surgery on the spine and how it should be applied. He has noted that Hartford and Southington have a large 
market segment for this type of surgery. He has also reviewed the different manufacturers and manufacturing processes of this type of surgery. This revealed that the key players to watch in 2018 are Zimmer-Biomet, Stryker, NuVasive, Medtronic, and DePuy Synthes.
He also uncovered that the market for minimally invasive surgery in general will reach $50.60 billion by the end of next year. Unfortunately, because there are so many different players involved in this market, it is highly fragmented. The leading players are Given Imaging Ltd., Siemens Healthcare, NuVasive Inc., Teleflex Inc., the Stryker Corporation, and Varian Medical Systems Inc. The fact that this list is not exactly the same as those who focus on spinal surgery in particular showcases some of that market fragmentation.
Numerous devices in particular are becoming increasingly important in the field of medical science. Those include the electrosurgical devices, the medial robotic systems, and the ablation devices. Indeed, it is expected that those three will continue to dominate the market. The health care infrastructure in this country is quite robust, which is why it is likely that there will be a particularly strong North American presence in the market as a whole.
Meanwhile, one of the reasons why there has been such tremendous growth in minimally invasive surgery and their associated devices, on the spine and on the rest of the body, is because there has been a continued growth in people who develop chronic physical health conditions. As a result, more and more people have to go under the knife. Since minimally invasive surgery is much safer as open surgery, and as it is associated with shorter downtime and recovery time, it stands to reason that physicians the world over are becoming more interested in it.
Some of the conditions Michael Giuffrida treats through minimally invasive procedures include cardiovascular disease, arthritis, kidney stones, cancers, and appendicitis. There has been a significant spike in diagnoses of these conditions and, therefore, also in demand for surgical procedures. It is expected that this demand will continue to grow and that this will have a positive impact on the market value of the minimally invasive surgery device manufacturers. At the same time, it showcases that further medical research has to be completed in order to ensure the procedures themselves are carried out as safely as possible.
Staff Writer; Barry Reed
